mhurhangee/ep-ind-claims huggingface dataset:
A chromatographic medium, comprising: a separating agent layer, configured to separate target substances; and a permeation layer, which is laminated so as to face the separating agent layer and which is configured to enable permeation of the target substances separated by the separating agent layer, wherein a region in which the permeation layer is not present is present on a part of the separating agent layer in a region of the chromatographic medium between a dip end part, which is dipped in a developing solution used to develop the target substances, and half the length of the chromatographic medium in a direction of development, and configured for spotting the target substances, wherein the separating agent layer exhibits separating property for the target substances and exhibits optical responsiveness to ultraviolet rays, and wherein the permeation layer exhibits optical responsiveness to ultraviolet rays that is different from those of the target substances and the separating agent layer. a separating agent layer, configured to separate target substances; and a permeation layer, which is laminated so as to face the separating agent layer and which is configured to enable permeation of the target substances separated by the separating agent layer, wherein a region in which the permeation layer is not present is present on a part of the separating agent layer in a region of the chromatographic medium between a dip end part, which is dipped in a developing solution used to develop the target substances, and half the length of the chromatographic medium in a direction of development, and configured for spotting the target substances, wherein the separating agent layer exhibits separating property for the target substances and exhibits optical responsiveness to ultraviolet rays, and wherein the permeation layer exhibits optical responsiveness to ultraviolet rays that is different from those of the target substances and the separating agent layer.
A method for backing up a video, the method comprising: receiving, in a camera device, a first setting instruction from a mobile terminal; setting, in said camera device, a recording parameter according to said first received setting instruction, said first setting instruction comprising at least one of the following instructions: an instruction for setting recording quality, an instruction for setting video file group period and an instruction for setting a time length of each video file; recording by said camera device a video file according to said recording parameter; characterized in that, the method further comprises: receiving by a local router, a second setting instruction from said mobile terminal; backing up the recorded video file by said local router, according to storage parameters set according to the second setting instruction. receiving, in a camera device, a first setting instruction from a mobile terminal; setting, in said camera device, a recording parameter according to said first received setting instruction, said first setting instruction comprising at least one of the following instructions: an instruction for setting recording quality, an instruction for setting video file group period and an instruction for setting a time length of each video file; recording by said camera device a video file according to said recording parameter; characterized in that, the method further comprises: receiving by a local router, a second setting instruction from said mobile terminal; backing up the recorded video file by said local router, according to storage parameters set according to the second setting instruction. receiving by a local router, a second setting instruction from said mobile terminal; backing up the recorded video file by said local router, according to storage parameters set according to the second setting instruction.
Servo steering system, in particular power steering system for a vehicle, having a motion screw which is driven by a servo motor and which is composed of a nut which is mounted in axially non-displaceable fashion in a frame, and having an axially displaceable component, whose thread engages with a nut thread of the nut, and having a belt pulley which is connected rotationally conjointly to the nut and which is part of a traction mechanism drive between the servo motor and the nut, wherein the nut is mounted in the frame by way of a rolling bearing, wherein the pulley is formed from a plastic, characterized in that an inner ring of the rolling bearing bears axially against a radially directed stop, which is formed integrally with the nut, and against a stop which is formed integrally with the belt pulley and which lies in the same plane as the stop of the nut.
A heavy duty tire comprising a carcass extending from a tread part through a sidewall part to a bead core of a bead part and a belt layer arranged outside in a tire radial direction of the carcass and inside of the tread part, wherein the belt layer is formed by a belt ply comprising a first belt layer, a second belt layer, and a third belt layer which are laminated in order from inside in the tire radial direction, wherein the tread has a plurality of main grooves extending continuously in a tire circumferential direction, wherein the tread comprises a cap rubber layer constituting a tread surface and a base rubber layer adjacent to inside in a tire radial direction of the cap rubber layer, wherein the cap rubber layer and the base rubber layer are composed of a rubber composition comprising a rubber component, wherein the rubber component constituting the cap rubber layer comprises an isoprene-based rubber and a butadiene rubber, characterised in that the rubber composition constituting the cap rubber layer comprises 30 parts by mass or more of silica having a nitrogen adsorption specific surface area (N 2 SA) of 200 to 250 m 2 /g based on 100 parts by mass of the rubber component, and a tan δ of the rubber composition constituting the base rubber layer at 70°C is 0.04 to 0.07, wherein the "70°C tan δ" refers to a loss tangent tan δ under a condition of a temperature at 70°C, an initial strain of 10%, a dynamic strain of ± 2%, and a frequency of 10 Hz, and wherein the N 2 SA of silica is a value measured by a BET method according to ASTM D3037-93. wherein the belt layer is formed by a belt ply comprising a first belt layer, a second belt layer, and a third belt layer which are laminated in order from inside in the tire radial direction, wherein the tread has a plurality of main grooves extending continuously in a tire circumferential direction, wherein the tread comprises a cap rubber layer constituting a tread surface and a base rubber layer adjacent to inside in a tire radial direction of the cap rubber layer, wherein the cap rubber layer and the base rubber layer are composed of a rubber composition comprising a rubber component, wherein the rubber component constituting the cap rubber layer comprises an isoprene-based rubber and a butadiene rubber, characterised in that the rubber composition constituting the cap rubber layer comprises 30 parts by mass or more of silica having a nitrogen adsorption specific surface area (N 2 SA) of 200 to 250 m 2 /g based on 100 parts by mass of the rubber component, and a tan δ of the rubber composition constituting the base rubber layer at 70°C is 0.04 to 0.07, wherein the "70°C tan δ" refers to a loss tangent tan δ under a condition of a temperature at 70°C, an initial strain of 10%, a dynamic strain of ± 2%, and a frequency of 10 Hz, and wherein the N 2 SA of silica is a value measured by a BET method according to ASTM D3037-93.
A patient interface assembly for delivering respiratory therapy to a patient, comprising: a housing that defines an inlet port and an outlet port, the inlet port being configured to couple to a driver delivering pressurized gas flow to the inlet port; a jet pump (328, 330) disposed within the housing and slidable within the housing in a direction relative to the inlet port and the outlet port, the jet pump being positioned to receive the pressurized gas flow from the inlet port and deliver the pressurized gas flow to the outlet port; a nebulizer port fluidly coupled to the outlet port to receive the pressurized gas flow therefrom, introduce medication into the pressurized gas flow and deliver medicated gas flow to the patient; characterized in that the patient interface assembly further comprises: an exhalation port configured to exhaust air from the housing; and a progressive seal positioned in the housing such that, as the jet pump (328, 330) slides toward the outlet port, a gradual seal forms between the exhalation port and the outlet port. a housing that defines an inlet port and an outlet port, the inlet port being configured to couple to a driver delivering pressurized gas flow to the inlet port; a jet pump (328, 330) disposed within the housing and slidable within the housing in a direction relative to the inlet port and the outlet port, the jet pump being positioned to receive the pressurized gas flow from the inlet port and deliver the pressurized gas flow to the outlet port; a nebulizer port fluidly coupled to the outlet port to receive the pressurized gas flow therefrom, introduce medication into the pressurized gas flow and deliver medicated gas flow to the patient; characterized in that the patient interface assembly further comprises: an exhalation port configured to exhaust air from the housing; and a progressive seal positioned in the housing such that, as the jet pump (328, 330) slides toward the outlet port, a gradual seal forms between the exhalation port and the outlet port. an exhalation port configured to exhaust air from the housing; and a progressive seal positioned in the housing such that, as the jet pump (328, 330) slides toward the outlet port, a gradual seal forms between the exhalation port and the outlet port.
A coordinate measuring machine comprising: a base for supporting an object; a movable assembly having a probe for measuring the object; a rail guiding the movable assembly along its length, the rail comprising carbon and having a rail CTE, with CTE = coefficient of thermal expansion; and an air bearing member circumscribing the rail and fixedly coupled with the movable assembly, the air bearing member forming a radial air bearing with the rail and having a member CTE, the rail CTE being about equal to the member CTE. a base for supporting an object; a movable assembly having a probe for measuring the object; a rail guiding the movable assembly along its length, the rail comprising carbon and having a rail CTE, with CTE = coefficient of thermal expansion; and an air bearing member circumscribing the rail and fixedly coupled with the movable assembly, the air bearing member forming a radial air bearing with the rail and having a member CTE, the rail CTE being about equal to the member CTE.
A process for producing an aqueous dispersion of a polymer P by free-radically initiated aqueous emulsion polymerization of ethylenically unsaturated compounds, which comprises using ≥ 0.1 and ≤ 5.0 wt% of at least one α,β-monoethylenically unsaturated C 3 to C 6 mono- or dicarboxylic acid (monomers A), ≥ 0.1 and ≤ 10 wt% of at least one monoethylenically unsaturated compound having at least one epoxy group (monomers B), ≥ 0.1 and ≤ 5.0 wt% of at least one monoethylenically unsaturated compound having at least one sulfonic acid group (monomers C), ≥ 70 and ≤ 95 wt% of at least one ester formed from vinyl alcohol and a C 1 to C 5 monocarboxylic acid (monomers D), and ≥ 0 and ≤ 25 wt% of at least one ethylenically unsaturated compound other than said monomers A to D (monomers E), wherein the amounts of monomers A to E sum to 100 wt%, for the polymerization.
A method for wireless communications by a transmitter, comprising: determining whether intra-slot frequency hopping is enabled or disabled for a particular slot; determining, based on an intra-slot frequency hopping pattern, a first set of frequency resources available for transmitting uplink control information, UCI, within a first set of symbols of the slot of a transmission time interval, TTI, and a second set of frequency resources available for transmitting UCI within a second set of symbols of the slot, wherein the intra-slot frequency hopping pattern is determined based on a number of symbols that are allocated to transmitting the UCI in the slot; and transmitting the UCI using the determined first set of frequency resources and the second set of frequency resources. determining whether intra-slot frequency hopping is enabled or disabled for a particular slot; determining, based on an intra-slot frequency hopping pattern, a first set of frequency resources available for transmitting uplink control information, UCI, within a first set of symbols of the slot of a transmission time interval, TTI, and a second set of frequency resources available for transmitting UCI within a second set of symbols of the slot, wherein the intra-slot frequency hopping pattern is determined based on a number of symbols that are allocated to transmitting the UCI in the slot; and transmitting the UCI using the determined first set of frequency resources and the second set of frequency resources.
A method of wirelessly updating software at an in-vehicle gateway of a vehicle, the method comprising: obtaining (S2, S3) a software module list: from at least one controller of the vehicle, the software module list indicating one or more software modules which are currently installed in each of the at least one controller; transmitting, to an update server, a diagnose submit message including the software module list for each of the at least one controller, for checking whether updates of the software modules are needed, wherein the software module list includes hardware version information for each of the at least one controller, characterized in that the diagnose submit message further includes locale field indicating region information of the vehicle, and the hardware version information and the region information are used for determining whether updates of the software modules are needed for each of the at least one controller; and by receiving, from the update server, an update check response message which includes download location information of at least one update module and an actions element, wherein: the download location information includes two or more URL addresses, at least one of which is a backup URL address, and the actions element indicates information about actions to be performed to install the at least one update module once the at least one update module has been successfully downloaded. obtaining (S2, S3) a software module list: from at least one controller of the vehicle, the software module list indicating one or more software modules which are currently installed in each of the at least one controller; transmitting, to an update server, a diagnose submit message including the software module list for each of the at least one controller, for checking whether updates of the software modules are needed, wherein the software module list includes hardware version information for each of the at least one controller, characterized in that the diagnose submit message further includes locale field indicating region information of the vehicle, and the hardware version information and the region information are used for determining whether updates of the software modules are needed for each of the at least one controller; and by receiving, from the update server, an update check response message which includes download location information of at least one update module and an actions element, wherein: the download location information includes two or more URL addresses, at least one of which is a backup URL address, and the actions element indicates information about actions to be performed to install the at least one update module once the at least one update module has been successfully downloaded. the download location information includes two or more URL addresses, at least one of which is a backup URL address, and the actions element indicates information about actions to be performed to install the at least one update module once the at least one update module has been successfully downloaded.
A control device for an access point (2-n) comprising an input/output interface connected to a communication bus using a communication protocol, a transmitting stage suitable for converting a first signal from said input/output interface into a transmitted light signal, and a receiving stage suitable for converting a received light signal into a second signal passed on to said input/output interface, characterized in that it is arranged either to disable said receiving stage when said input/output interface receives a first signal from said communication bus, and to enable said receiving stage when said input/output interface no longer receives a first signal from said communication bus, or to disable said transmitting stage when said receiving stage receives a light signal, and to enable said transmitting stage when said receiving stage no longer receives a light signal.
Use of an injection solution containing mRNA and an aqueous injection buffer, wherein the injection buffer contains a sodium salt, a calcium salt and a potassium salt, for the preparation of a medicament for the treatment and/or prevention of cancer and tumor diseases, allergies, autoimmune diseases, viral and/or bacterial infections, for gene therapy and for vaccination, in particular anti-viral vaccination, for prevention of the afore-mentioned diseases, wherein the injection solution is for increasing the mRNA transfer and/or the mRNA translation into/in a host organism, wherein the use of isolated and/or mixed mRNA in a Ringer-Lactate solution (pH 5-7) with a theoretic osmolarity of 276 mosm/l and with a titration acidity of 0.5-2 mmol NaOH/l, consisting of - 6.0 g NaCl, - 0.4 g KCI, - 0.27 g CaCl 2 -dihydrate - 6.34 g Na- -lactate-solution with 3.17 g Na-lactate - in 1000 ml infusion solution with the further components: - hydrochloric acid 25% and sodium hydroxide, both for pH value adjustment and - water for injection purposes (w.f.i.), for the preparation of a medicament for treating cancer- and tumor diseases, is disclaimed. - 6.0 g NaCl, - 0.4 g KCI, - 0.27 g CaCl 2 -dihydrate - 6.34 g Na- -lactate-solution with 3.17 g Na-lactate - in 1000 ml infusion solution with the further components: - hydrochloric acid 25% and sodium hydroxide, both for pH value adjustment and - water for injection purposes (w.f.i.),
A method for introducing a soft metal into a hard coating during a physical vapor deposition process, said method comprising steps of: providing a substrate; depositing a bonding layer on the substrate; and depositing the hard coating on the bonding layer using vapor deposition wherein the soft metal being Ag is deposited to start layer formation and the layer formation is interrupted in order to avoid full coalescence in such way that the soft metal forms islands contained in the hard coating being metal nitrides, carbides, or combination of those with metals Ti, Zr, Ta, Al, Si, Cr. providing a substrate; depositing a bonding layer on the substrate; and depositing the hard coating on the bonding layer using vapor deposition wherein the soft metal being Ag is deposited to start layer formation and the layer formation is interrupted in order to avoid full coalescence in such way that the soft metal forms islands contained in the hard coating being metal nitrides, carbides, or combination of those with metals Ti, Zr, Ta, Al, Si, Cr.
A pharmaceutical composition comprising a therapeutically effective amount of a cyclohexenone compound having the structure: wherein each of X and Y independently is oxygen, NR 5 or sulfur; R is a hydrogen or C(=O)C 1 -C 8 alkyl; each of R 1, R 2 and R 3 independently is a hydrogen, optionally substituted methyl or (CH 2) m -CH 3; R 4 is NR 5 R 6, OR 5, OC(=O)R 7, C(=O)OR 5, C(=O)R 5, C(=O)NR 5 R 6, halogen, 5 or 6-membered lactone, C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, aryl, glucosyl, wherein the 5 or 6-membered lactone, C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, aryl, and glucosyl are optionally substituted with one or more substituents selected from NR 5 R 6, OR 5, OC(=O)R 7, C(=O)OR 5, C(=O)R 5, C(=O)NR 5 R 6, C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 3 -C 8 cycloalkyl, and C 1 -C 8 haloalkyl; each of R 5 and R 6 is independently a hydrogen or C 1 -C 8 alkyl; R 7 is a C 1 -C 8 alkyl, OR 5 or NR 5 R 6; m = 1-12; and n=1-12; or a pharmaceutically acceptable salt, or solvate thereof; for use in treating or reducing the risk of leukemia in a subject. R is a hydrogen or C(=O)C 1 -C 8 alkyl; each of R 1, R 2 and R 3 independently is a hydrogen, optionally substituted methyl or (CH 2) m -CH 3; R 4 is NR 5 R 6, OR 5, OC(=O)R 7, C(=O)OR 5, C(=O)R 5, C(=O)NR 5 R 6, halogen, 5 or 6-membered lactone, C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, aryl, glucosyl, wherein the 5 or 6-membered lactone, C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, aryl, and glucosyl are optionally substituted with one or more substituents selected from NR 5 R 6, OR 5, OC(=O)R 7, C(=O)OR 5, C(=O)R 5, C(=O)NR 5 R 6, C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 3 -C 8 cycloalkyl, and C 1 -C 8 haloalkyl; each of R 5 and R 6 is independently a hydrogen or C 1 -C 8 alkyl; R 7 is a C 1 -C 8 alkyl, OR 5 or NR 5 R 6; m = 1-12; and n=1-12; or a pharmaceutically acceptable salt, or solvate thereof; for use in treating or reducing the risk of leukemia in a subject.